1.
Holbrook AM, Pullenayegum EM, Troyan SM, Nikitovic M, Crowther MA. PERSONALIZED BENEFIT-HARM INFORMATION INFLUENCES PATIENT DECISIONS REGARDING WARFARIN. J Popl Ther Clin Pharmacol [Internet]. 2018 Nov. 21 [cited 2024 Nov. 19];20(3). Available from: https://mail.jptcp.com/index.php/jptcp/article/view/370